http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Changing Innovation in the Pharmaceutical Industry
Globalization and New Ways of Drug Development
The internationalization of research and technology is one key component of the globalization of trade and business, with potentially major impacts on patterns of economic development and public policies worldwide. Particularly in the already highly globalized pharmaceutical industry, innovation processes have changed considerably in the last 15 - 20 years. One-dimensional, linear single-actor type processes are being replaced by multi-dimensional, complex, multi-actor schemes. As a consequence, new players are becoming more important, with biotechnology firms playing a key role. This study analyzes these new ways in drug development in pharmaceuticals within the concept of "national systems of innovations" as well as from the perspectives of different actors, and collects a lot of empirical evidence for the assumed type of changes, its repercussion on significant input measures and on the differing performance of national pharmaceutical industries.
Introduction -- The National System of Innovation in the United States and Germany -- Dynamics of the Markets and Market Structure -- Innovation Process and Techno-scientific Dynamics -- Generation, Transfer and Exploitation of New Knowledge -- Internationalization of Research and Development in Pharmaceuticals -- Case Study on New Therapies for Selected Autoimmune Diseases -- Summary and Conclusions. The complete table of contents can be found on the Internet: http://www.springer.de.
edited by Andre Jungmittag, Guido Reger, Thomas Reiss.
Industrial organization (Economic theory)